Growing demand for personalized medicine is driving growth

Company logo

Company logo

Global Medical Diagnostics Market

Global Medical Diagnostics Market

Global Medical Diagnostics Market

Dublin, September 16, 2022 (GLOBE NEWSWIRE) – The Clinical Diagnostics Market: Global Industry Trends, Participation, Size, Growth, Opportunities and Forecast 2022-2027 Report added to ResearchAndMarkets.com Show.

The global clinical diagnostics market size was US$ 71.39 billion in 2021. Looking ahead, the publisher expects the market to reach US$ 102.99 billion by 2027, with a compound annual growth rate of 6.3% during the period 2021-2027. Keeping in mind the uncertainties related to COVID-19, we are constantly tracking and evaluating the direct and indirect impact of the pandemic on various end-use sectors. These insights are included in the report as a major contributor to the market.

Clinical Diagnostics Market Trends:

Nowadays, there is a rising prevalence of chronic diseases, such as cancer, heart disease, stroke, diabetes and arthritis, worldwide. This, along with the increasing adoption of automated platforms for disease prevention, detection and management, is one of the key factors driving the market. Furthermore, there is an increase in the practice of lipid panel tests to measure total cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, low-density lipoprotein (LDL) cholesterol, HDL, and non-HDL cholesterol.

This, along with the high death rate due to the increase in cardiovascular diseases, is driving the growth of the market. Besides, the growing awareness among individuals about the benefits of laboratory tests provides profitable growth opportunities for industry investors.

Apart from this, the increasing use of clinical diagnostics by healthcare providers to develop targeted therapies through specific and sensitive diagnostic tests is fueling the growth of the market. In addition, the increasing demand for personalized medicine among patients positively affects the market.

Main market segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global Clinical Diagnostics market, along with forecasts at the global, regional and country levels from 2022-2027. Our report ranked the market based on testing, product and end user.

Breakup by test:

Breakdown by product:

  • Tools

  • reagents

  • Aharon

Differentiate by end user:

  • hospital laboratory

  • Diagnostic lab

  • point of care test

  • Aharon

Division by region:

  • North Amarica

  • United State

  • Canada

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Aharon

  • Europe

  • Germany

  • France

  • United kingdom

  • Italia

  • Spain

  • Russia

  • Aharon

  • Latin america

  • Brazil

  • Mexico

  • Aharon

  • Middle East and Africa

Main topics covered:

1 Introduction

2 Scope and methodology

3 Executive Summary

4 Introduction

5 Global Clinical Diagnostics Market

6 Market Breakdown by Test

7 Market segmentation by product

8 Market disintegration by the end user

9 Market segmentation by region

10 SWOT Analysis

11 Value Chain Analysis

12 Porter’s Five Forces Analysis

13 Price Analysis

14 Competitive Scene

mentioned companies

  • Abbott Laboratories

  • Becton Dickinson & Co

  • bioMerieux SA

  • Bio-Rad Laboratories Company

  • Danaher Corporation

  • F. Hoffmann-La Roche AG

  • Qiagen NV

  • Quest Diagnostics Incorporated

  • Siemens AG

  • Sysmex Corporation

  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/r/y6c9r2

Attached

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Leave a Comment